Psychedelic Medicine Continues Its Rapid Evolution The field of interventional psychiatry is undergoing one of its most transformative periods in decades. Following renewed interest in ketamine, esketamine, psilocybin, and other novel neuroplasticity-promoting therapies, another important milestone has emerged. Definium Therapeutics... The post A Single Dose of an LSD-Derived Therapy for Depression? Phase 3 Results Signal a Potential New Era in Psychedelic Medicine appeared first on Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences .